MedPath

VO659

Generic Name
VO659
Drug Type
Biotech
CAS Number
1479142-52-3

Overview

VO659 is an antisense oligonucleotide being investigated for the treatment of Huntington's disease.

Background

VO659 is an antisense oligonucleotide being investigated for the treatment of Huntington's disease.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Phase 1
Recruiting
Posted: 2023/04/21
Sponsor:
Vico Therapeutics B....

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath